Connect with us

Cannabis News

What Do New Ohio Restrictions On Marijuana And Hemp Mean For Consumers And Businesses?

Published

2 months ago

on

It is currently illegal to bring recreational cannabis products into Ohio, even if purchased legally in another state.

By Frank W. Lewis, Signal Cleveland

It was this story originally posted By Signal Cleveland. Sign up for their free newsletter at SignalCleveland.org/subscribe.

Intoxicating hemp products and THC-infused drinks are illegal again in Ohio and the maximum potency of the extracts is lower as a result The law entered into force on March 20.

Ohio voters legalized recreational marijuana and related products in 2023 when they passed Proposition 2. Republican lawmakers almost immediately vowed to roll back parts of it, and did so late last year, passing the new cuts mostly along party lines.

Here are some of the changes, including new criminal penalties for improperly transporting personal stash, bringing THC products across state lines or carrying them in public.

No more smoking or vaping in public places or businesses

You can attend a privately owned property if it’s not even a daycare center, halfway house, or community residential center.

Renters can still smoke in a house or apartment unless the lease prohibits it.

What are the new rules for storing edibles and weeds?

Edible and medical marijuana and other products should be stored in their original containers, even after opening.

What about driving with herbs, edibles or extracts?

If the original package has been opened, it should be stored in the trunk of your vehicle or behind the rear seats if there is no trunk. In other words, out of the driver’s hand.

The same rules apply to pipes, vape and other marijuana paraphernalia.

There are no out-of-state marijuana races or orders

It is currently illegal to bring recreational cannabis products into Ohio, even if purchased legally in another state. (Looking at you, Michigan.)

Sellers of these products, including edibles and grocers, cannot ship these products in Ohio.

Can I Door Dash or Uber Eats Marijuana?

Not right now. But the new law opens the door to home delivery of medical marijuana once the Cannabis Control Division drafts rules and standards.

Is it still legal to share marijuana with friends?

Yes, but with some changes.

  • The handover must be done in a private house or in an agricultural space.
  • The amount shared in one day cannot exceed 2 ½ ounces of plant material (excluding seeds and plants) or 15 grams of extract.
  • You still can’t take money for kindly sharing your eye.

Did they confuse it with power?

yes The THC level of the extracts is limited to 70 percent (below 90 percent).

The limit on medicinal and recreational plants remains at 35 percent.

Can I go to jail for using recreational cannabis products?

Yes, if it violates your employer’s policies.

That was true under Issue 2, the law passed by voters in 2023. But under the new law, workers fired for violating the drug policy are not eligible for state unemployment benefits.

I can still grow marijuana at home, right?

Home growing is still an option and the limit is six plants per adult over 21 or a total of 12 per home.

However, growing even one plant over that limit can lead to a charge of illegal marijuana cultivation, which can lead to criminal penalties.

No edibles in the form of gummy bears or fruit snacks

The new law outlaws the sale of marijuana products that resemble fictional characters, real people, animals, fruit, or images that may appeal to children.

Changing who gets tax revenue from the sale of marijuana

The new law eliminates the social equity and jobs fund created by No. 2 and money for substance abuse and addiction education and treatment programs.

Cities with dispensaries still receive 36% of tax revenue and the rest goes to the state’s general fund. Sales of recreational marijuana products in Ohio were $836 million last year.

For more information on all the latest changes, check out this side-by-side comparison table from Ohio State’s Moritz College of Law. Read the full set of legislative changes here.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Related Topics:
Continue Reading

Cannabis News

Livermore Falls debates cannabis licensing fees

Published

8 hours ago

on

May 13, 2026

By











Existing medical cannabis licensing fees will be temporarily applied to recreational marijuana businesses, the Select Committee decided on May 5. Board members agreed 4-1 to the temporary change, as long as officials say the fees are higher than necessary and accurately reflect the town’s oversight costs.

Bryce Cobb, Livermore Falls’ code enforcement officer, plumbing inspector, health officer and E-911 dispatcher, said voters approved the amended cannabis ordinance on April 28. Cobb said the amended ordinance allows recreational marijuana businesses and the next step was to establish a fee schedule. Recreational cannabis businesses operating in town would require local licensing approval under the ordinance.

Asked if he had fee schedules from other towns to compare, Cobb said he did not. Additionally, the town’s fee schedule specifically mentions medicinal cannabis.

“So it could be medical and adult use,” Cobb said when discussing whether the existing fee structure could apply to recreational businesses.

Read more at Sun Magazine










Continue Reading

Cannabis News

Georgia Governor Signs Bill To Expand Medical Marijuana Access By Allowing Vaping And Adding New Qualifying Conditions

Published

8 hours ago

on

May 13, 2026

By

The governor of Georgia has signed a bill expand access to medical marijuana in the state.

SB 220, which was approved by Gov. Brian Kemp (R) on Tuesday, will add new requirements to the program, allow patients to vape medical cannabis, and change THC potency limits, among other reforms.

Under the legislation, patients with lupus will be allowed access to medical marijuana, under current state law that allows people with cancer, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, ALS, autism spectrum disorder, intractable pain and other conditions to qualify.

The bill by Sen. Matt Brass (R) removes many of the requirements for a patient to be in a critical or terminal condition to enter the medical cannabis program.

The reform will also expand how patients can use medical marijuana. Until now, they have been able to obtain oils, tinctures, capsules, lozenges, topicals and transdermal patches, but the new law will also allow vaping as a form of vaping for patients over 21, while continuing to ban smoking for all patients.

The Putting Georgia’s Patients First Act also replaces the current 5 percent THC potency limit on medical cannabis products with a limit of 12,000 milligrams of THC that a patient can possess at any one time.

“These changes, while meaningful to affected patients, do not materially change where Georgia stands in the national landscape on this issue,” Kemp said in a signing statement. “This bill passed with a constitutional majority in both houses of the General Assembly.”

“I, like many who opposed this bill, have reservations about legalizing recreational cannabis. Many states that have legalized recreational cannabis have regretted that decision,” he said. “I also recognize that for some patients, medical cannabis provides significant relief from symptoms that would otherwise be untreated or treated with even more harmful opioids.”

“I do not believe that a well-implemented medical cannabis program should inevitably lead to the legalization of recreational use in Georgia, nor is the issue of recreational use on the bill on my desk for signature,” the governor said.

The invoice also replaces references to “low THC oil” in current laws with “medical cannabis.”

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

The Georgia Medical Cannabis Access Commission, which oversees the program, “will have a new duty to inform citizens, law enforcement and health care providers about the effective uses of medical cannabis and its products, including publishing materials and conducting outreach and public education activities to inform the public, law enforcement and health care providers about this state’s medical cannabis program and the potential benefits for patients.”

Last year, the leaders of the Chamber a Blue-Ribbon Study Committee on Georgia’s Medical Marijuana and Hemp Policies to examine state cannabis laws.

Georgia lawmakers have also considered the legislation supporting research into the therapeutic benefits of psychedelics.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

EU regulators say Charlotte’s Web hemp CBD safety “cannot be established”

Published

1 day ago

on

May 12, 2026

By

The growing tension between international scientific findings and US health policy has raised questions about whether Medicare beneficiaries are being exposed to cannabinoid products whose safety profiles have not been fully established.

In March 2026, the European Food Safety Authority (EFSA) carried out a formal scientific evaluation of a shipment of Charlotte’s Web hemp product, concluding that the safety of a carbon dioxide extract derived from Cannabis sativa L. “cannot be established”. The agency identified several gaps in the available data, including significant portions of the product remaining uncharacterized, a lack of reliable toxicological studies on the actual material, a lack of human clinical data, and an unknown allergenicity and long-term safety profile.

At the same time, the Centers for Medicare and Medicaid Services (CMS) launched the Substance Access Beneficiary Engagement Incentive (BEI) program. The initiative allows participating healthcare providers to discuss and supply certain hemp and marijuana-derived cannabinoid products to Medicare beneficiaries under the authority of the Center for Innovation, and does not require approval from the US Food and Drug Administration. That distinction is at issue in a pending federal case: Smart Approaches to Marijuana (SAM), et al. Robert F. Kennedy Jr. et al., Case 1:26-cv-01081 (U.S. District Court for the District of Columbia).

Under the FDA’s standard framework, products intended for therapeutic use typically undergo controlled clinical trials, dose standardization, safety and toxicology evaluation, and manufacturing and stability validation. The BEI program operates outside of this structure. Some observers point out that this could introduce products into federally funded care settings before those benchmarks are met, while proponents of the program characterize it as a legitimate model of innovation.

Medicare beneficiaries represent a medically complex population, with many patients managing multiple medications, chronic conditions, and increased susceptibility to drug interactions. Cannabinoid compounds, including THC, interact with metabolic pathways such as CYP450 enzymes, which process many common medications. The safety profile of these products in this population has not been fully characterized through controlled studies.

Following the launch of the program, several companies publicly announced their positioning within the emerging healthcare supply chain. Charlotte’s Web highlighted alignment with CMS drivers and Cornbread Hemp announced institutional distribution through a national group buying organization, reflecting broader commercialization activity in the category.

SAM v. In Kennedy, the court is evaluating whether CMS overstepped its statutory authority by introducing avenues for the supply of cannabinoids without formal regulations, public notice and comment, or FDA validation standards. A resolution will determine whether the program is scaled back, modified, or stopped pending further review as implemented.

The EFSA’s conclusion does not ban the marketing of CBD products, but indicates that the scientific evidence necessary to fully establish their safety remains incomplete. The political debate reflects a broader question in health care regulation: how to balance the pace of innovation for therapeutic products with the standards of evidence typically required in federally funded systems of care.

Source: MMJ International Holdings

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media